FeaturesSignalPricingFounders
Log inGet started free
BI

Bioventures Investors

Venture CapitalActive

Bioventures Investors is an investment firm focused on the commercial development of advanced technology in life sciences and healthcare.

Wellesley, United StatesFounded 2012bioventuresinvestors.com/
32
Investments
8
Exits
$205M
AUM
25.0%
Exit Rate

Get contact info, warm intros & fit scores

Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Bioventures Investors.

Get started free

Investment Thesis & Strategy

Bioventures Investors invests in various stages of healthcare and life science companies with advanced technologies, focusing on commercial development.

Investment Activity

Deals per year over the last 9 years

1
2013
1
2014
2
2015
1
2016
0
2017
3
2018
2
2019
0
2020
2
2021

Portfolio Companies

Selected investments from their portfolio of 32 companies

I
Inceptor Bio
Biotech · Series A, 2021
Active
O
Obsidio
Biotech · Series A, 2021
Active
T
Tvardi Therapeutics
Biotech · Series A, 2019
Active
X
Xilio Therapeutics
Biotech · Series A, 2019
Active
T
Triumvira Immunologics
Biotech · Series A, 2018
Active
V
Vaxcyte
Biotech · Series B, 2018
Active
T
TScan Therapeutics
Biotech · Series A, 2018
Active
C
Codiak BioSciences
Biotech · Series B, 2016
Active
K
Kiadis Pharma
Biotech · Growth, 2015
Active
I
Immatics
Biotech · Series B, 2015
Active
R
Rgenix
Biotech · Series A, 2014
Active
A
Aeglea BioTherapeutics
Biotech · Series A, 2013
Active

Frequently Asked Questions

Bioventures Investors focuses on Series A, Series B, Series C+ stage investments.

Related Investors

North Bridge Venture Partners & Growth Equity

Wellesley, United States · 412 deals

Kodiak Venture Partners

Wellesley, United States · 134 deals

Castile Ventures

Wellesley, United States · 44 deals

Venture Capital Fund of New England

Wellesley, United States · 34 deals

Inflection Point Ventures

Wellesley, United States · 19 deals

Walnut Venture Associates

Wellesley, United States · 10 deals